Quaker Partners is an East Coast-focused healthcare investment firm. The funds that we manage pursue a traditional venture capital strategy, leading equity investments in healthcare companies at all stages of development. Our industry expertise includes pharmaceuticals, biotechnology, healthcare services, and medical technologies such as devices, tools and human diagnostics. Since its founding in 2002, Quaker has invested in dozens of innovative, high impact healthcare companies. Quaker manages over $700 million in committed capital, and is currently investing its second fund.
35
Total Investments
20
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Funding Stage
Seed +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Quaker BioVentures
Recent Investments (35)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series F | •••••• | Apr 2015 | |
| Debt Financing | •••••• | Sep 2013 | |
| Series E | •••••• | Apr 2013 | |
| Series A | •••••• | Sep 2012 | |
| Series B | •••••• | Mar 2012 | |
|
|
Series D | •••••• | Jun 2011 |
|
|
Series E | •••••• | May 2011 |
|
|
Series D | •••••• | Jan 2011 |
|
|
Series C | •••••• | Jan 2011 |
|
|
Series D | •••••• | Sep 2010 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.